These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23806471)

  • 1. Immunoglobulin G4-related disease presenting as an ethmoid and maxillary mass.
    Hu EK; Parrish C; Wrobel B; Deshpande V; Stone JH
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):75-7. PubMed ID: 23806471
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapsing course of immunoglobulin G4-related pachymeningitis.
    Shapiro KA; Bové RM; Volpicelli ER; Mallery RM; Stone JH
    Neurology; 2012 Aug; 79(6):604-6. PubMed ID: 22843267
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous immunoglobulin G4-related systemic disease.
    Khosroshahi A; Carruthers MD; Deshpande V; Leb L; Reed JI; Stone JH
    Am J Med; 2011 Oct; 124(10):e7-8. PubMed ID: 21722865
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis.
    Caso F; Fiocco U; Costa L; Sfriso P; Punzi L; Doria A
    Joint Bone Spine; 2014 Mar; 81(2):190-2. PubMed ID: 23932926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low-frequency vibrations in the treatment of patients with acute maxillary sinusitis and ethmoiditis. Non-specific resistance and immunity].
    Zelenkin EM; Prozorovskaia KN; Mirkin AS; Zavgorodniaia EG; Kandaurova AN
    Vestn Otorinolaringol; 1998; (3):41-3. PubMed ID: 9662979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G4-related sclerosing inflammatory pseudotumors presenting in the oral cavity.
    Ono K; Shiiba M; Yoshizaki M; Ogawara K; Ishihara T; Yonemori Y; Oide T; Uzawa K; Nakatani Y; Tanzawa H
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1593-8. PubMed ID: 21978720
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria.
    Arkwright PD
    J Allergy Clin Immunol; 2009 Feb; 123(2):510-1; author reply 511. PubMed ID: 19203667
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe Bickerstaff's encephalitis treated with Rituximab: serum and CSF GQ1b antibodies.
    Hardy TA; Barnett MH; Mohamed A; Garsia RJ; Davies L
    J Neuroimmunol; 2012 Oct; 251(1-2):107-9. PubMed ID: 22868227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired haemophilia A treated with Rituximab in a patient with prostatic melioidosis.
    Kalro AK; Currie B; Szabo F
    Haemophilia; 2012 May; 18(3):e74-5. PubMed ID: 22531026
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab in anti-glomerular basement membrane disease.
    Shah Y; Mohiuddin A; Sluman C; Daryanani I; Ledson T; Banerjee A; Crowe A; McClelland P
    QJM; 2012 Feb; 105(2):195-7. PubMed ID: 21258056
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy for chronic periaortitis.
    Maritati F; Corradi D; Versari A; Casali M; Urban ML; Buzio C; Vaglio A
    Ann Rheum Dis; 2012 Jul; 71(7):1262-4. PubMed ID: 22586161
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.
    Mellon-Reppen S; Ratanatharathorn V; Cronin S; Uberti JP
    Bone Marrow Transplant; 2010 Dec; 45(12):1758-9. PubMed ID: 20383208
    [No Abstract]   [Full Text] [Related]  

  • 14. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.
    Wong PC; Fung AT; Gerrie AS; Moloney G; Maberley D; Rossman D; White V; Collins D; Coupland R; Chen LY
    Eur J Haematol; 2013 Mar; 90(3):250-6. PubMed ID: 23278107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis. What about treatment with monoclonal antibodies?].
    Marignier R; Confavreux C
    Rev Prat; 2010 Mar; 60(3):304-6. PubMed ID: 20402115
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.
    Chiba T; Tsuji G; Mitoma H; Takahara M; Moroi Y; Miyamoto T; Furue M
    Haemophilia; 2013 Mar; 19(2):e98-9. PubMed ID: 23419110
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E; Karras A; Plaisier E; Duong Van Huyen JP; Fakhouri F; Rougier JP; Noel LH; Callard P; Delahousse M; Ronco P
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Castleman's disease, HIV and rituximab].
    Valencia ME; López V; Corcuera MT; Del Val D
    Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab in pemphigus.
    Kanwar AJ; Vinay K
    Indian J Dermatol Venereol Leprol; 2012; 78(6):671-6. PubMed ID: 23075635
    [No Abstract]   [Full Text] [Related]  

  • 20. [IgG4-related disease: patient group characterization and rituximab therapy].
    Sedyshev SKh; Vasil'ev VI; Kovrigina AM; Logvinenko OA; Rodionova EB; Safonova TN; Gaĭduk IV; Silin AIu; Komov DV; Nasonov EL
    Ter Arkh; 2013; 85(2):48-53. PubMed ID: 23653939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.